Webinar: Drug Pricing and Reporting Regulatory Updates Part 2

In Part 2 of our Drug Pricing and Reporting Regulatory Updates webinar, EVERSANA revenue experts Michael Kurland and Brian Bumpus take a look at the Final Rule, which was released by the Centers for Medicare and Medicaid Services in December 2020.

Legislative actions related to the rule will go into effect through 2023. This webinar specifically looks at how the following factors will affect pricing for manufacturers:

  • Coupons, Vouchers, Accumulators
  • Line Extensions/Oral Solid Dosages
  • Average Manufacturer Price for Authorized Generics
  • Supplemental Rebates to Medicaid MCOs

Watch Part 1 of the Drug Pricing and Reporting Regulatory Updates webinar here for the latest Biden administration updates.  

For an in-depth look at current drug pricing and drug price reporting regulatory updates, download the white paper. 

Author
Mike Kurland
Michael Kurland
Vice President, Revenue Management & Compliance Solutions

With more than 2 decades of experience in the pharmaceutical and biotech industries, Michael helps clients navigate the complex public and private payer marketplace. He has a proven reputation for helping manufacturers balance their…

Brian Bumpus
Brian Bumpus
Associate Director

With more than 20 years of experience, Brian is a seasoned pharmaceutical industry contracting executive with broad experience in government pricing, and commercial contract management and compliance matters. His specialized expertise is in the…